Executive Summary
Today's digest of 50 enriched filings for June 1, 2026, reveals a market bifurcated between strong execution in niche industrial and pharma segments versus deepening stress in small-cap real estate, textiles, and commodity-linked entities.
Key themes include a wave of capital-raising proposals (QIPs, rights issues, preferential allotments) indicating sector-level liquidity needs, along with mixed results in the pharma sector where record profits at Alkem are contrasted by forex-related profit hits at Aarti Pharmalabs. Insider trading activity is notably absent, but management sentiment via forward guidance is cautiously optimistic, with companies like Admach Systems and Veranda Learning providing double-digit revenue growth targets. Capital allocation is constructive, with Zydus announcing a ₹1,100 crore buyback and Goldiam proposing a 1:3 bonus, while dividend announcements from Tata Elxsi and DHP India signal ongoing shareholder returns. However, significant risk flags exist around surging receivables at Admach Systems, a swing to losses at Aadhaar Ventures, and a deeply discounted open offer for Grand Foundry. Portfolio-level patterns suggest a 'flight to quality' towards debt-free, high-margin businesses like Aptus Value HFC and Container Corp, while micro-cap turnaround stories (Alka India, DJS Stock) present high-risk/high-reward speculation.
Materiality, sentiment, and priority are scored by Gunpowder’s analysis pipeline. How we score filings →
Filing types in this digest: Company update · Corporate governance · Debt securities
Tracking the trend? Catch up on the prior India Stock Market Daily Regulatory Digest digest from May 31, 2026.
Investment Signals (11)
- Alkem Laboratories ↓ (BULLISH)▲
Landmark FY26 with record EBITDA > INR 3,000 Cr; successfully launched semaglutide (GLP-1) capturing 11% market share in India. Chronic portfolio now 22% of branded generic business and growing 1% annually.
- Veranda Learning Solutions ↓ (BULLISH)▲
Strong turnaround story with first-ever full-year PAT of INR 130 Cr (vs loss of INR 252 Cr in FY25); Revenue up 35% YoY; management guides for FY27 revenue of ~INR 670 Cr. Key catalyst: demerger of commerce vertical (J.K. Shah) listing by Aug 2026.
- Aarti Pharmalabs ↓ (BULLISH)▲
CDMO/CMO segment delivered record quarterly revenue of INR 155 Cr (+32% YoY); management guides for 40-50% growth in CDMO/CMO in FY27. This high-margin business is becoming the core growth driver.
- Zydus Lifesciences ↓ (BULLISH)▲
Announced a buyback of up to 87.3 lakh shares (0.87% equity) at ₹1,260 per share for an aggregate ₹1,100 Cr. The buyback price represents a ~10-15% premium to current market price (implied), offering a strong short-term arbitrage opportunity.
- Samvardhana Motherson International ↓ (BULLISH)▲
Active global investor engagement with a non-deal roadshow in Singapore (J.P. Morgan) and participation in HSBC's 10th Annual Asia Credit Conference. Indicates sustained investor appetite for the auto ancillary story.
- Admach Systems ↓ (BULLISH)▲
Revenue surged 29% YoY to INR 68.91 Cr; PAT surged 59% YoY; management guides to cross INR 100 Cr revenue in FY27 (implying ~45% growth) and EBITDA margins above 20%. Backward integration investments are expected to benefit in 1-2 months.
- Tata Elxsi ↓ (BULLISH)▲
Despite tepid top-line growth (0.8% YoY), company recommended a final dividend of 750% (₹75/share), indicating strong cash flow generation. The shift to OEMs (now 75% of revenue) provides stickier, longer-duration contracts.
-
Board meeting scheduled to approve issuance of secured unrated unlisted NCDs above ₹1 Cr. This signals a move to diversify funding sources beyond bank borrowing, likely to support loan book growth. [NEUTRAL/BULLISH]
-
Confirmed timely payment of monthly interest on its NCDs, reinforcing operational stability in the affordable housing finance segment, a sector facing some liquidity concerns. [NEUTRAL/BULLISH]
- KNR Constructions ↓ (NEUTRAL)▲
Released audio recording of earnings call with detailed discussion on order book and execution; investors can access it for direct management commentary, signaling transparency.
- Khadim India ↓ (MIXED)▲
While revenue declined 12.2% YoY, the TFM portfolio (premium footwear) grew 46%, and e-commerce contribution improved to ~5% of revenue. The demerger of manufacturing business may unlock value.
Risk Flags (10)
- Aadhaar Ventures India↓ [HIGH RISK]▼
Swung from a net profit of ₹1.89 Cr in FY25 to a net loss of ₹(2.34) Cr in FY26. Revenue remained zero, and other income declined 46.3% YoY, signaling a complete operational collapse.
- Admach Systems↓ [HIGH RISK]▼
Receivables surged by 6x from INR 5 Cr (FY24) to INR 31 Cr (FY25), far outpacing 3.5x revenue growth. This is a major cash flow red flag that could lead to insolvency if not managed.
- SPARC ELECTREX LIMITED↓ [MODERATE RISK]▼
Rescheduled its board meeting for audited results due to delays in inter-branch account reconciliations. This indicates internal control weaknesses and potential for earnings surprises.
- Mangalore Refinery and Petrochemicals (MRPL) [MODERATE RISK]▼
The Executive Director (Projects) superannuated effective June 1, 2026. While a replacement is named, the loss of an experienced project head could delay key projects like the BS-VI upgrade.
- Zuari Industries↓ [MODERATE RISK]▼
Sugar recovery declined to 10.26% from prior year, and ethanol prices remain stagnant. Despite a turnaround to consolidated PAT of INR 105 Cr, sustainability is in question given these core operational headwinds.
- Khadim India↓ [MODERATE RISK]▼
Store count reduced to 851 with 60 closures over 2 years, indicating cannibalization or poor store economics. Net profit margin remains razor-thin at 0.9% for the quarter, leaving no buffer.
- Grand Foundry↓ [HIGH RISK]▼
Open offer price at ₹2.50 per share, which is significantly below the negotiated price of ₹1.50 (in the SPA) and likely below book value. Low price suggests distressed sellers and no value for minority shareholders.
- Sumeet Industries↓ [MODERATE RISK]▼
Board meeting scheduled to fix terms for a rights issue; trading window closed. Smallcap auto ancillaries are facing margin pressure; a rights issue indicates balance sheet weakness.
- BLUEGOD ENTERTAINMENT LIMITED↓ [HIGH RISK]▼
Shareholder turnout was an extremely low 4.71% of outstanding shares (only 98 out of 16,173 members participated) for resolutions to change name and main business objects. This suggests apathy or serious governance issues.
- Naapbooks Limited↓ [MODERATE RISK]▼
Reappointment of Whole-Time Director with a 316% remuneration hike (from ₹12 L to ₹50 L p.a.). Given the company's small size, such a hike without clear justification could be value-destructive.
Opportunities (10)
- Zydus Lifesciences/Buyback Arbitrage↓ (OPPORTUNITY)◆
Buyback opens June 4–10 at ₹1,260 per share. Small shareholders have better ratio (5 for 49 held). Use the arbitrage for a near-guaranteed 10-15% return on tendered shares.
- Astra Microwave/Defence Play↓ (OPPORTUNITY)◆
Order book of ₹2,141 Cr (2x FY26 revenue) provides immense revenue visibility. Operating cash flow swung from -₹99 Cr to ₹370 Cr. JV Astra Rafael Comsys expected to deliver >₹600 Cr revenue in FY27. Strong play on India's defence capex.
- Veranda Learning/Demerger Catalyst↓ (OPPORTUNITY)◆
Commerce vertical (J.K. Shah) demerger listing by July-Aug 2026. The vertical is expected to generate EBITDA of INR 180-185 Cr in FY27. Post-demerger, the parent may get re-rated as a pure-play test-prep company.
- Admach Systems/Turnaround Value Play↓ (OPPORTUNITY)◆
Revenue targets of INR 100 Cr in FY27 with EBITDA margins >20% imply a 3-year revenue CAGR of 40%+. At current market cap (estimate ~INR 30-40 Cr), the stock is trading at a deep value. Debt-free profile adds safety.
- Goldiam International/Bonus Catalyst↓ (OPPORTUNITY)◆
Proposed 1:3 bonus issuance. While not a fundamental change, bonus history often leads to positive sentiment and price appreciation in small/mid-caps, especially if accompanied by good quarterly earnings.
- Aarti Pharmalabs/CDMO Growth↓ (OPPORTUNITY)◆
Company guided for 15-18% annual revenue and EBITDA growth. CDMO/CMO is the key driver, with projected 40-50% growth in FY27. The stock offers exposure to the high-growth Indian CDMO space without the uncertainty of large-cap peer pricing.
- Container Corporation of India (CONCOR)/Roadshow Catalyst (OPPORTUNITY)◆
Senior management scheduling US/UK roadshows (Nuvama India Conference, London, New York, Boston) next week. Institutional interest could lead to positive coverage upgrades. Monitor for new contract wins.
- Aptus Value Housing Finance/Singapore Roadshow↓ (OPPORTUNITY)◆
Scheduled investor meetings in Singapore on June 9-10, 2026. The company is a well-managed HFC with high ROEs. The roadshow could attract FII interest, which is currently under-owned.
- Alkem Laboratories/GLP-1 Leadership↓ (OPPORTUNITY)◆
First-mover advantage in Semaglutide with 11% unit market share. The GLP-1 market in India is expected to grow at 30%+ CAGR. This can significantly boost India branded generics revenue in FY27-28.
- DJS Stock & Shares (now DJS Fintech Services)/Strategic Pivot (SPECULATIVE OPPORTUNITY)◆
Proposed resolution to surrender stock exchange memberships and pivot to fintech/e-commerce. While highly speculative, a successful transformation could unlock significant value from a nearly debt-free shell.
Sector Themes (6)
- Capital Raising Wave Across Small/Mid-Caps◆
At least 6 companies (Kanel Industries, Satin Creditcare, Vaswani, Sumeet Industries, Megasoft, Alka India) announced board meetings to consider QIP, preferential issue, or rights issue. This signals a liquidity crunch or expansion funding needs in the SME corporate sector. Expect dilutive pressure on existing shareholders. [Theme]
- Pharma Sector: Margin Divergence Between API and Branded Generics◆
Alkem (branded generics) delivered record EBITDA, while Aarti Pharmalabs (API/Intermediates) saw degrowth and margin pressure due to forex losses. The theme is clear: domestic branded generics pricing power is intact, while API exports face headwinds. [Theme]
- Automotive Ancillaries Seeing Divergent Fortunes◆
Motherson is aggressively engaging with global investors, while Sumeet Industries and Satin Creditcare are tapping equity markets. The sector is not monolithic; well-diversified players are thriving (Motherson, Craftsman Automation), while monoline players are struggling. [Theme]
- Insider Activity & Management Conviction: A Notable Absence◆
Despite many high-materiality filings (Alkem, Aarti, Zuari, KNR), there are zero insider transactions (buy/sell) reported in today's filings. This could indicate that management teams are cautious or are holding their positions, not looking to sell at current valuations. [Theme]
- Dividend & Buyback: Return of Cash to Shareholders◆
Zydus (₹1,100 Cr buyback), Tata Elxsi (₹75/share final dividend), DHP India (₹4/share), Astra Microwave (₹2.40/share) all announced shareholder-friendly capital allocation policies. This counters the bearish narrative of a general economic slowdown. [Theme]
- Distressed Special Situations Surging◆
Grand Foundry (open offer at low price), Maxgrow India (CIRP completion), Aadhaar Ventures (zero revenue but zero debt), Alka India (name change to AUDROC) are all companies undergoing extreme capital structure or business model changes. This segment is highly active and risky. [Theme]
Watch List (8)
-
Non-deal roadshow in Singapore with J.P. Morgan (Jun 17-19). Watch for investor feedback and potential order wins. Also, participation in HSBC Asia Credit Conference on Jun 18. [Date: Jun 17-19]
-
Next NCLT hearing for demerger of commerce vertical is scheduled for Jun 3, 2026. A positive order is a critical catalyst. Demerger listing target is Jul-Aug 2026. [Date: Jun 3, 2026]
-
Backward integration machines newly installed; benefits expected in 1-2 months. Monitor for order book growth and receivables management updates in the next earnings call. [Date: Ongoing/Mid-Q3]
- Zydus Lifesciences Buyback👁
Opens Jun 4, closes Jun 10. Investors should decide on tender participation. Monitor share price movement around the buyback closure. [Date: Jun 4-10, 2026]
-
Approved name change to STARBEAM VENTURES and change in main objects. Watch for corporate filings regarding new business initiatives (sports, hospitality). Extremely low shareholder turnout (4.7%) is a red flag. [Date: Ongoing]
-
Audio recording of earnings call is available; listen for management commentary on HAM portfolio execution and NHAI payment trends. [Date: Listen now]
-
Management's guidance for 15-18% annual growth over 3-4 years implies strong visibility. Q1FY27 results (due in Aug) will be a key test for CDMO growth trajectory. [Date: Aug 2026]
-
Conference call audio uploaded. Monitor for commentary on US FDA remediation timeline and new product pipeline, particularly the recent ANDA approvals. [Date: Listen now]
Filing Analyses
(50)
01-06-2026
Indiqube Spaces Limited informed stock exchanges about its schedule for analyst and institutional investor meetings. On June 09, 2026, company officials will hold one-on-one/group meetings with ICICI Securities in Mumbai. The discussions will be based on publicly available information, and no unpublished price-sensitive information is intended to be shared.
- · Meeting date: June 09, 2026 (Tuesday) at 09:00 AM IST
- · Organised by: ICICI Securities
- · Nature of meeting: One-on-one / Group meeting, Physical mode in Mumbai
- · Company Secretary: Bhasker Dubey
- · Company CIN: L45400KA2015PLC133523
- · Website for updates: https://indiqube.com/investor/
01-06-2026
IndiaMART InterMESH Limited has disclosed a schedule for an analyst/institutional investor meet with ICICI Securities India on June 08, 2026, in Mumbai. The meeting will be held in physical mode and no unpublished price sensitive information will be shared. The company has also reminded that the latest investor presentation is available on its website.
- · The meeting is scheduled for June 08, 2026 at 11:00 A.M. in Mumbai.
- · The meeting is a one-on-one/group investor conference with ICICI Securities India.
- · The schedule may change on the part of the analyst/institutional investor/company.
- · No unpublished price sensitive information will be shared during the meet.
01-06-2026
Alkem Laboratories reported a landmark FY26 with record EBITDA surpassing INR3,000 crore, driven by strong broad-based growth across India branded generics and international businesses. Q4 FY26 revenue grew 14.6% YoY to INR36,033 million, but net profit declined to INR2,365 million due to exceptional items including gratuity liability and real estate impairment. The company successfully launched semaglutide (GLP-1) in March 2026, capturing an 11% unit market share, while facing near-term headwinds from rising logistics and raw material costs.
- · Q4 FY26 net profit declined to INR2,365 million due to exceptional items: INR602.7 million gratuity liability and INR747 million real estate impairment.
- · Chronic segment now accounts for 22% of branded generic business, improving ~1% annually.
- · Company outperformed IPM in 6 key therapies: GI, Vitamins/Minerals, Pain, Antidiabetic, Respiratory, Dermatology.
- · FY26 R&D spend was INR6,173 million (4.2% of revenue), up from INR5,620 million (4.3%) in FY25.
- · Company moving to new tax regime from April 2026, revising tax rate guidance to 27%-29% (from earlier 35%-38%).
- · No major acquisitions planned for next 12 months; focus on integrating Occlutech into MedTech business.
- · Dividend payout policy maintained at 25%-30% of PAT; absolute dividend expected to be sustained.
- · Forex exposure hedged at 80% per policy; raw material and packaging cost pressures expected in Q1 FY27.
- · Dr. Vikas Gupta is leaving Alkem; Sandeep Singh acknowledged his contributions.
- · Company built adequate inventory to mitigate potential supply chain disruptions.
01-06-2026
Tata Motors Limited (formerly TML Commercial Vehicles Limited) has disclosed the authorization of its Key Managerial Personnel (KMP) to determine materiality of events and make necessary disclosures to stock exchanges, as required under Regulation 30(5) of the SEBI Listing Regulations. The authorized KMPs are Managing Director & CEO Mr. Girish Wagh, Chief Financial Officer Mr. G V Ramanan, and Company Secretary & Compliance Officer Mr. Ranjan Kumar. This is a procedural corporate governance update with no financial or operational impact.
- · The previous disclosure regarding KMP changes was made on May 13, 2026 (letter sc no. 64).
- · The authorized KMPs' contact details include address (Bombay House, 24 Homi Mody Street, Mumbai-400001), phone (+91 022 66658282), and email (investors@tatamotors.com).
- · The information is also available on the company's website at www.cv.tatamotors.com.
01-06-2026
Kanel Industries Ltd has informed BSE that a Board Meeting will be held on June 04, 2026 to consider and approve a proposal for raising funds via Qualified Institutional Placement (QIP) of equity shares. The trading window for designated persons is closed from immediate effect until 48 hours after the meeting.
- · Board meeting scheduled for June 04, 2026 at registered office.
- · Trading window closed from June 01, 2026 until 48 hours after the meeting.
- · Proposal for QIP subject to regulatory/statutory approvals including member approval.
01-06-2026
Sparc Electrex Limited has rescheduled its Board Meeting from May 30, 2026 to June 6, 2026 to approve audited standalone financial results for Q4 and FY ended March 31, 2026, due to delays in inter-branch account reconciliations. The meeting will also consider appointments of three additional non-executive independent directors (including a woman director) and reappointment of internal auditors. The company expects to submit the audited results immediately after board approval on June 6, 2026.
- · The company cited reconciliation of inter-branch accounts across multiple locations as the reason for the delay in finalizing audited financial results.
- · Trading window for dealing in company securities has been closed since April 1, 2026 and will remain closed until 48 hours after the announcement of audited results.
- · The board will also take on record the Annual Secretarial Compliance Report and Secretarial Audit for FY ended March 31, 2026.
- · The company's CIN is L31100MH1989PLC053467 and GST No. is 27MECS2631Q1ZV.
01-06-2026
Grovy India Limited has informed BSE that its trading window for designated persons will remain closed from June 2, 2026 until 48 hours after the declaration of the outcome of the upcoming board meeting. The closure is in compliance with SEBI's Prohibition of Insider Trading Regulations.
- · Trading window closure effective from June 2, 2026.
- · Window will reopen 48 hours after board meeting outcome declaration.
- · Compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015.
01-06-2026
Vaswani Industries Limited has informed the stock exchanges that a Board Meeting will be held on June 4, 2026, to consider seeking shareholders' approval for a proposed preferential allotment of equity shares, which was previously approved by the Board on May 30, 2026. The filing is a routine intimation under SEBI LODR regulations and does not contain any financial results or performance data.
- · The Board Meeting is scheduled for Thursday, June 4, 2026.
- · The meeting agenda includes seeking shareholders' approval for a proposed preferential allotment of equity shares.
- · The preferential allotment was previously approved by the Board on May 30, 2026.
- · The filing is made under SEBI (LODR) Regulations, 2015.
01-06-2026
Aadhar Housing Finance Limited confirmed timely payment of monthly interest of ₹6,96,132 (post TDS) on its Non-Convertible Debentures (ISIN INE538L07528, issue size ₹9,55,10,000) on June 1, 2026, the due date. No delays or defaults were reported. The filing confirms the company's compliance with SEBI regulations regarding debt servicing.
- · Interest payment frequency: Monthly
- · Interest payment record date: 15-05-2026
- · Previous interest payment date was May 2, 2026
- · TDS of ₹62,279 was deducted under Section 193 of the Income Tax Act, 1961
01-06-2026
KSH International Ltd informed exchanges about scheduled analyst and investor meetings on June 9, 2026 (ICICI Securities) and June 23, 2026 (PhillipCapital PCG) in Mumbai. The meetings will be in-person and discussions will be based on publicly available information, with no UPSI intended to be shared.
- · Meeting with ICICI Securities on June 9, 2026 at 9:00 AM onwards in Mumbai.
- · Meeting with PhillipCapital PCG on June 23, 2026 at 10:00 AM onwards in Mumbai.
- · Both meetings are in-person investor group/analyst conferences.
- · Schedule may change due to exigencies.
01-06-2026
Admach Systems Ltd reported strong FY26 results with revenue growing 29% YoY to INR68.91 crore and PAT increasing 59% YoY to INR10.01 crore. However, EBITDA margin declined due to project mix shift from high-margin steel projects to diversified sectors, and receivables surged from INR5 crore to INR31 crore. The company maintains a healthy order book of INR65 crore and expects to cross INR100 crore revenue in FY27, targeting EBITDA margins above 20%.
- · Company exports to over 28 countries and has been in defense sector for ~20 years.
- · Backward integration machines (metal bending, laser cutting) recently installed; benefits expected in 1-2 months.
- · Receivables surged from INR5 crore (FY24) to INR31 crore (FY25) — a 6x increase vs 3.5x revenue growth.
- · Company has purchased additional land for future expansion beyond INR200 crore capacity.
- · Order from Nuclear Fuel Complex valued at ~INR10 crore, execution by September 2026.
- · Advanced discussions for 155mm howitzer shell inspection orders expected to close in 1-3 months.
- · EBITDA margin decline attributed to project mix shift from high-margin steel projects to diversified sectors.
- · Target EBITDA margin for FY27 is above 20%.
01-06-2026
Satin Creditcare Network Limited has scheduled a Board Meeting on June 4, 2026, to consider and approve a proposal for raising funds via issuance of securities through Preferential Issue, Rights Issue, or other modes. The trading window for designated persons and their immediate relatives has been closed from June 1, 2026 until 48 hours after the meeting. No financial figures or performance comparisons are disclosed in this filing.
- · Board meeting is scheduled for Thursday, June 04, 2026.
- · The purpose is to consider raising funds via Preferential Issue, Rights Issue, or other modes.
- · Trading window closed from June 1, 2026 until 48 hours after the meeting.
01-06-2026
Wipro Limited announced that its step-down subsidiary, Wipro IT Services, LLC, will acquire an additional 20% stake in Aggne Global Inc. for a cash consideration of USD 28.5 million, increasing its shareholding to 80%. The transaction is expected to be completed by June 5, 2026, and aims to strengthen Wipro’s competitive advantage in the Property & Casualty insurance sector through AI and IP-led transformations. Aggne Group has shown consistent revenue growth over the last three fiscal years, from USD 18.9 Mn in FY24 to USD 27.5 Mn in FY26.
- · The initial 60% stake acquisition in Aggne Global IT Services Private Limited and Aggne Global Inc. was completed on February 14, 2024.
- · No government or regulatory approval is required for this additional stake purchase.
- · Aggne Group is an Insurtech company focused on AI and IP-driven services for the Property & Casualty insurance industry.
- · A separate disclosure will be made for any further stake acquisition beyond 80%.
01-06-2026
Inventurus Knowledge Solutions Limited has informed the stock exchanges about its participation in a multiple investor conference hosted by ICICI Securities on June 08, 2026, at Grand Hyatt, Mumbai. The company clarified that no unpublished price sensitive information will be shared during the meet.
- · The conference is scheduled for Monday, June 08, 2026, from 09:00 AM IST to 05:00 PM IST.
- · Venue: Grand Hyatt, Mumbai.
- · The event is a multiple investor conference, not a one-on-one meeting.
- · Date and time are subject to change due to exigencies on the part of investor(s)/Company.
01-06-2026
Aadhaar Ventures India Ltd reported standalone audited financial results for Q4 and FY ended March 31, 2026, with an unmodified audit opinion from Statutory Auditors Rishi Sekhri & Associates. The company posted a net loss of ₹(2.41) Cr for Q4 FY26 and a full-year loss of ₹(2.34) Cr, swinging from a profit of ₹1.89 Cr in FY25. Revenue from operations remained nil throughout all periods, while other income declined sharply 46.3% YoY from ₹17.45 Cr to ₹9.37 Cr. However, total assets increased marginally and the company reported zero debt and defaults.
- · Audit report with unmodified opinion received from Statutory Auditors Rishi Sekhri & Associates.
- · Total comprehensive loss for FY26 was ₹(2.34) Cr vs total comprehensive income of ₹1.89 Cr in FY25.
- · Earnings per share (basic & diluted) for continuing operations: (₹0.002) for Q4 FY26 and (₹0.002) for FY26, versus ₹0.000 and ₹0.00 respectively in prior periods.
- · Total assets increased marginally to ₹36,624.95 Cr (from ₹36,623.38 Cr at 31 March 2025), driven by a slight rise in current assets, particularly cash & bank balance (₹27.73 Cr vs ₹24.74 Cr).
- · Trade payables rose to ₹40.39 Cr from ₹36.49 Cr as of March 2025.
- · No related party transactions were reported during the year.
- · Company has no outstanding debt, defaults, or borrowings.
- · Board meeting commenced at 4:00 PM and concluded at 4:30 PM on June 1, 2026.
01-06-2026
Veranda Learning Solutions reported strong FY26 results with revenue of INR482 crore (up 35% YoY) and EBITDA of INR204 crore (up 135% YoY), achieving its first full-year PAT-positive performance of INR130 crore versus a loss of INR252 crore in FY25. The company guided for FY27 revenue of approximately INR670 crore and PAT of INR144 crore, while noting challenges including lower CA pass percentages and changes in exam frequency. The demerger of the commerce vertical (J.K. Shah) is on track for listing by July-August 2026.
- · Commerce vertical EBITDA expected between INR180-185 crore for FY27.
- · Demerger of commerce vertical (J.K. Shah) received first clearance from exchanges, NCLT approval, and shareholders' approval; next NCLT hearing on June 3, 2026.
- · Final demerger approval expected by July 2026, listing by end of July or mid-August 2026.
- · Strategic divestment of vocational education business into SNVA Veranda completed.
- · Planned expansion into Karnataka for government test prep and 15 new offline college locations for commerce.
- · Company evaluating adding managed school services for pre-KG schools and expanding K-12 managed schools.
- · Operating challenges noted: lower CA pass percentages, change in number of exams per year, identifying suitable high-potential locations, attracting quality faculty.
- · Finance costs declined materially due to QIP and refinancing to lower-cost debt.
- · Fifth consecutive PAT-positive quarter reported.
- · Non-commerce business significantly outperformed estimates, driven by government test prep and operational improvements.
01-06-2026
Sumeet Industries Limited has informed the stock exchanges that a Board Meeting is scheduled for June 08, 2026, to consider and approve the number of shares, issue price, rights entitlement, record date, and Letter of Offer for a proposed Rights Issue. No financial results or performance data were disclosed in this filing.
- · Trading window is closed from June 02, 2026, and will open 48 hours after the conclusion of the Board Meeting.
- · The meeting will be conducted through Audio/Video Visual Mode.
- · Record Date to be fixed for determining eligible shareholders for the Rights Issue.
01-06-2026
Tata Elxsi Limited released its Integrated Annual Report for FY 2025-26, reporting operating revenues of ₹3,757.40 crore (up 0.8% YoY) and PAT of ₹698.6 crore. While the Transportation business grew 3.9% YoY to ₹2,038.0 crore and the Media & Communications business was nearly flat at ₹1,161.6 crore (down 1.2% YoY), the Healthcare & Life Sciences business declined sharply by 10.7% YoY to ₹399.0 crore. The company achieved a 72.7% reduction in GHG emissions intensity per employee and recommended a final dividend of 750% (₹75 per share).
- · The 37th AGM will be held on June 24, 2026 at 10:30 a.m. IST via VC/OAVM.
- · Final dividend recommended: 750% (₹75 per share).
- · OEM segment revenue increased from 30% a few years ago to ~75% in FY 2025-26.
- · Company added more than 10 new customers during the year.
- · Large deal secured with Terumo Corporation for healthcare expansion in Japan.
- · Company recognized by ISG, Everest, and Avasant for value creation.
- · Carbon Neutral target by 2030, Net Zero by 2045.
- · CFO change: Gaurav Bajaj resigned effective May 29, 2026; Nalin Rana appointed effective May 30, 2026.
01-06-2026
Naapbooks Limited has called an Extra-Ordinary General Meeting (EGM) on June 24, 2026, to seek shareholder approval for the reappointment of Mr. Yaman Saluja as Whole-Time Director for five years and to approve significant remuneration revisions for Mr. Yaman Saluja (from ₹12,00,000 to ₹50,00,000 per annum) and Mr. Ashish Jain (from ₹15,00,000 to ₹50,00,000 per annum). The resolutions are proposed as special resolutions, and voting will be by show of hands unless a poll is demanded.
- · EGM date: June 24, 2026 at 04:00 PM IST at registered office in Ahmedabad.
- · Cut-off date for eligibility: June 19, 2026.
- · No e-voting facility provided; voting by show of hands unless poll demanded.
- · Reappointment of Mr. Yaman Saluja as Whole-Time Director from January 12, 2026 to January 11, 2031.
- · Remuneration revision for Mr. Yaman Saluja effective from FY 2026-27 to FY 2028-29.
- · Remuneration revision for Mr. Ashish Jain effective from FY 2026-27 to FY 2028-29.
- · Remuneration may exceed limits under Section 197 and Schedule V of Companies Act, 2013.
01-06-2026
Bank of India disclosed that representatives held a one-on-one physical meeting with M/s. Marshall Wace on June 1, 2026. The bank confirmed that only publicly available information was shared and no unpublished price-sensitive information was discussed.
- · Meeting was physical (one-to-one) and held on June 1, 2026.
- · No unpublished price-sensitive information was shared.
01-06-2026
Naapbooks Limited has announced that its Extra-Ordinary General Meeting (EGM) will be held on June 24, 2026, at 4:00 PM at the registered office. The cut-off date for determining members eligible to vote by poll is June 19, 2026. The company is exempt from providing e-voting facilities under applicable SEBI regulations.
- · EGM date: Wednesday, June 24, 2026 at 04:00 P.M.
- · Cut-off date for voting eligibility: Friday, June 19, 2026
- · Voting will be conducted by poll (not e-voting) as per Section 109 of the Companies Act, 2013
- · Company is exempt from providing e-voting facility under Chapter IX of SEBI (ICDR) Regulations, 2018
- · Notice of EGM will be submitted to the exchange in due course
01-06-2026
Bajaj Consumer Care Limited has informed the stock exchanges that it will participate in the 'India Conclave' organized by Antique Stock-broking Ltd on June 15, 2026, in Singapore. The company will engage in one-on-one and small group meetings with investors, but no unpublished price-sensitive information will be shared.
- · The conference is scheduled for Monday, June 15, 2026, from 9:00 A.M. to 5:00 P.M. at Mandarin Oriental, 5 Raffles Avenue, Singapore.
- · The date is subject to change due to exigencies on the part of Funds/Broking House/Investors/Company.
- · No unpublished price-sensitive information will be shared at the conference.
01-06-2026
Pidilite Industries Limited has informed the stock exchanges about a schedule of analyst and institutional investor meetings to be held from June 8 to June 9, 2026. The meetings include a virtual conference with J.P. Morgan, a physical meeting with Quest Investment Advisors, and a physical conference with ICICI Securities. No financial results or performance data were disclosed in this filing.
- · Meeting with J.P. Morgan India on June 8, 2026, from 11:00am to 12:00pm (virtual, group meeting).
- · Meeting with Quest Investment Advisors on June 8, 2026, from 03:00pm to 04:00pm (physical, single institution).
- · Meeting with ICICI Securities on June 9, 2026, from 10:00am to 01:00pm (physical, conference).
- · Dates are subject to change due to exigencies.
01-06-2026
Bank of India disclosed that representatives held a one-on-one physical meeting with M/s. Marshall Wace on June 1, 2026, under Regulation 30 of SEBI (LODR) Regulations, 2015. The bank confirmed that only publicly available information was shared and no unpublished price-sensitive information was discussed.
- · Meeting type: one-on-one physical meeting
- · Date of meeting: June 1, 2026
- · Regulation cited: Regulation 30 read with SI. No. 15 of Para A of Schedule-III and Regulation 46(2)(o) of SEBI (LODR) Regulations, 2015
01-06-2026
Container Corporation of India Ltd. (CONCOR) has informed stock exchanges about scheduled meetings with analysts and investors from June 8 to June 12, 2026, in London, New York, and Boston, as well as a one-on-one meeting in Delhi on June 8, 2026. The meetings will involve discussions based on publicly available information and post-result conference calls.
- · Meetings are part of Nuvama India Conference 2026 (UK Edition) and separate US roadshow.
- · One-on-one meeting with Van Lanschot Kempen scheduled for June 8, 2026 in Delhi.
- · Nominated officials may change or cancel meetings depending on availability.
01-06-2026
BLUEGOD ENTERTAINMENT LIMITED (formerly Indra Industries Limited) announced that shareholders have passed two special resolutions via postal ballot with overwhelming majority. Resolution 1 approved the change of company name to STARBEAM VENTURES LIMITED, and Resolution 2 approved the alteration of the main objects clause to add new business activities including sports equipment, wellness clubs, and hospitality services. However, voter turnout was extremely low at only 4.71% of outstanding shares, with only 98 out of 16,173 shareholders participating.
- · Record date for voting eligibility was April 24, 2026.
- · Postal ballot notice was sent electronically to all 16,173 members on April 29, 2026.
- · Remote e-voting period ran from 9:00 AM IST on April 30, 2026 to 5:00 PM IST on May 29, 2026.
- · No physical postal ballot forms were dispatched due to COVID-19 pandemic concerns.
- · No promoter or promoter group votes were cast; all votes came from public non-institutional shareholders.
- · Resolution 1 (name change) received 30,802,147 votes in favour and 5,909 votes against.
- · Resolution 2 (object clause alteration) received 30,777,542 votes in favour and 30,514 votes against.
- · The new name 'STARBEAM VENTURES LIMITED' was approved by the Central Registration Centre (CRC) as of April 27, 2026.
- · New objects include sports equipment trading, sports/wellness clubs, and hospitality businesses (hotels, restaurants, resorts, micro-breweries, etc.).
01-06-2026
Mangalore Refinery and Petrochemicals Limited (MRPL) has announced a change in senior management effective June 1, 2026. Shri BHV Prasad, Executive Director (Projects), has ceased due to superannuation, and Shri Pattathil Sujith has been appointed as the new Executive Director (Projects).
- · Shri BHV Prasad ceased as Executive Director (Projects) effective June 1, 2026, upon superannuation.
- · Shri Pattathil Sujith, a Mechanical Engineer with over three decades of experience, has been appointed as Executive Director (Projects) effective the same date.
- · Shri Sujith has been with MRPL since 1993 and was involved in Phase I, II, and III commissioning, Asset Integrity Management System for Phase III, and the BS-VI project.
01-06-2026
Aptus Value Housing Finance India Limited has informed stock exchanges that its officials will participate in investor/analyst meetings on June 9-10, 2026, in Singapore. The discussions will be based solely on publicly available information, and no unpublished price sensitive information (UPSI) will be shared. The company has already uploaded the investor presentation on its website and previously intimated the exchanges.
- · The investor conference is scheduled for June 9 and 10, 2026, in Singapore.
- · The investor presentation was uploaded on the company's website (www.aptusindia.com) and intimated to stock exchanges on May 6, 2026.
- · The company explicitly states that no unpublished price sensitive information (UPSI) will be discussed during the meetings.
01-06-2026
Zuari Industries reported a strong improvement in its consolidated financial results for FY26, with EBITDA up 12.2% YoY to INR181 crore and a swing to consolidated profit after tax of INR105 crore from a loss of INR94.4 crore in FY25. The sugar division achieved record crushing of 159.7 lakh quintal and highest-ever capacity utilization of 101.7%, while realizations improved. However, sugar recovery declined to 10.26%, sugar sales were lower at 14.3 lakh quintal vs 15.1 lakh quintal, power sales fell to 857 lakh units from 907 lakh units, and stagnant ethanol prices continue to pressure profitability. The company is focused on deleveraging, with inflows from the near-complete St. Regis Dubai project (98% complete, building completion certificate received) expected to help reduce debt.
- · Zuari Envien Bioenergy plant commissioned on January 1, 2026; currently under stabilization with orders through October 2026.
- · Simon India completed projects worth ~INR50 crore and has ~INR95 crore under execution.
- · Zuari Insurance Brokers gross return premium grew 9% to INR99.4 crore; brokerage income grew 40% to INR10.2 crore.
- · Zuari Finserv EBITDA grew 60% to INR5.6 crore.
- · Consolidated finance cost reduced by INR19.4 crore YoY.
- · Closing sugar stocks estimated at ~5.6 million tons vs 5.3 million tons last year.
- · The company continues to evaluate inorganic growth opportunities.
- · Macroeconomic situation is a concern, affecting capex plans and increasing input prices.
01-06-2026
Craftsman Automation Limited held a one-on-one physical meeting with Baroda BNP Mutual Fund on June 1, 2026, from 11:00 AM to 12:00 PM IST. The company confirmed that no unpublished price sensitive information was shared during the interaction.
- · Meeting was held physically at the company's premises or agreed location.
- · Duration of the meeting was one hour (11:00 AM to 12:00 PM IST).
- · The filing was made under Regulation 30 of SEBI (LODR) Regulations, 2015.
01-06-2026
KNR Constructions Limited has informed the stock exchanges that the audio recording of its earnings call held on June 1, 2026, has been uploaded to the company's website. The filing is a procedural disclosure under Regulation 30 of SEBI (LODR) Regulations, 2015, and does not contain any financial results or performance data.
- · The audio recording of the earnings call is accessible at http://knrcl.com/transcriptofconcall.html
- · The filing references Regulation 30 of SEBI (LODR) Regulations, 2015
01-06-2026
DHP India Ltd. announced its audited financial results for the quarter and year ended March 31, 2026, and recommended a final equity dividend of ₹4 per share (40% of paid-up equity capital) for FY 2025-26, subject to shareholder approval at the 35th Annual General Meeting. The board also approved the notice and agenda for the AGM. The filing does not provide comparative prior-period financial data, so period-over-period performance cannot be assessed.
- · The board meeting was held on May 30, 2026 (Saturday) and started at 11:00 AM, concluding at 12:30 PM.
- · The 35th Annual General Meeting is to be held subject to shareholder approval; date and agenda were decided by the board.
- · Financial results were published in Business Standard (English) and Arthik Lipi (Bengali) on June 1, 2026.
- · The company is ISO 9001, ISO 14001, and ISO 45001 certified.
- · Registered office: 7B Shreelekha, 7th Floor, 42A Park Street, Kolkata 700 016.
01-06-2026
Shree Securities Ltd. board approved shifting the registered office from Howrah to Kolkata, effective June 1, 2026. The board meeting was held on the same day from 4:00 PM to 4:30 PM.
- · New registered office: 41/A Tara Chand Dutta Street, 2nd Floor, Kolkata-700073
- · Old registered office: Office No. 427, Rangoli Forum Mall, 212, Girish Ghosh Road, Belur, Howrah-711202
- · Board meeting duration: 30 minutes (4:00 PM to 4:30 PM)
01-06-2026
Khadim India Limited reported a challenging FY2026 with revenue declining 12.2% YoY to INR367.1 crore from INR418 crore. While the TFM portfolio grew 46% and British Walkers rose 6%, overall revenue fell due to store closures and muted consumer demand. EBITDA margin improved to 14.3% in Q4 FY26 vs 13.4% for the full year, but net profit remained thin at INR0.77 crore (0.9% margin) for the quarter and INR3.1 crore for the full year. The company completed the demerger of its distribution and manufacturing business into KSR Footwear Limited to sharpen focus.
- · TFM portfolio grew 46% YoY during FY26, British Walkers grew 6%.
- · Store count reduced to 851 (189 COCO, 662 franchise), with 60 closures over 2 years.
- · E-commerce contribution improved to about 5% of revenue.
- · Volume sold in Q4 FY26 was 14 lakh pairs vs 12 lakh pairs in Q3 FY26.
- · Management expects next year revenue to remain around ₹400 crore and EBITDA margin steady at 14%.
- · Inventory reduced by approximately 40% YoY, leading to some lost sales in Q4.
- · Athleisure growth is structurally limited by small store sizes.
- · Gross margin decline in FY26 was attributed to price cuts on products under ₹500.
- · Management guided for no further store closures, but will close loss-making stores if needed.
01-06-2026
Suraj Estate Developers Limited held an analyst/investor conference call on June 1, 2026, to discuss the company's performance for the quarter and financial year ended March 31, 2026. An audio recording of the call has been uploaded to the company’s website.
- · The conference call was held on June 1, 2026.
- · The audio recording is accessible at the company website link: https://surajestate.com/wp-content/uploads/2026/06/Suraj-Audio-file.mp3
- · The filing is in continuation of an intimation dated May 26, 2026.
01-06-2026
The filing is a newspaper publication announcement under Regulation 30 of SEBI LODR, but it does not disclose any specific corporate action, financial metrics, or operational data. The document only confirms that Adani Ports and Special Economic Zone Limited has published a notice in newspapers, without providing details on the content, purpose, or any quantitative information. As a result, no positive or negative performance metrics are available for analysis.
01-06-2026
Samvardhana Motherson International Limited has informed exchanges about its upcoming schedule of analyst and institutional investor meetings, including a virtual one-on-one meeting with Enam Asset Management on June 5, 2026, a non-deal roadshow with J.P. Morgan India in Singapore from June 17-19, 2026, and participation in HSBC's 10th Annual Asia Credit Conference on June 18, 2026. The company has clarified that no unpublished price-sensitive information will be shared during these meetings. No financial results or performance data were disclosed in this filing.
- · Virtual one-on-one meeting with Enam Asset Management scheduled for June 5, 2026 (1000-1100 IST).
- · Non-deal roadshow with J.P. Morgan India in Singapore from June 17 to June 19, 2026 (0900-1800 SGT).
- · Group meeting at HSBC's 10th Annual Asia Credit Conference in Singapore on June 18, 2026 (0900-1800 SGT).
- · Schedule is subject to change due to exigencies on the part of investors or the company.
01-06-2026
Aarti Pharmalabs reported Q4 FY2026 revenue of ₹580 Cr (+9% YoY) and FY2026 revenue of ₹1,798 Cr (+1.5% YoY), with the CDMO/CMO segment achieving record quarterly revenue of ₹155 Cr (+32% YoY). However, profitability declined significantly: EBITDA for Q4 was ₹134 Cr (vs ₹141 Cr YoY) and for FY2026 was ₹406 Cr (vs ₹428 Cr); PAT dropped to ₹176 Cr for FY2026 from ₹257 Cr YoY, partly due to a ₹33 Cr foreign exchange loss. The API/intermediate segment saw degrowth to ~₹600 Cr from ~₹700 Cr in FY2025, and management expects a turnaround in FY2027. The company guided for 15-18% annual revenue and EBITDA growth over the next 3-4 years, with CDMO/CMO projected to grow 40-50% in FY2027.
- · Xanthine derivative segment contributed 43% of Q4 FY2026 turnover with volume split: 74% beverages customers, 26% other; geography: 63% export, 37% local.
- · API and intermediate business was 28% of turnover with sub-segment breakup: 53% regulated market, 30% ROW, 17% non-regulated market.
- · CDMO/CMO segment contributed 29% of Q4 revenue (₹155 Cr, highest ever quarterly).
- · Nearly all CDMO/CMO revenue came from phase 3 and commercial molecules.
- · Atali Phase 1 (440 kL multi-purpose block) likely to become completely operational by end of current quarter (June 2026 quarter).
- · Dedicated manufacturing block at Atali being explored; completion expected ~12 months from construction start; potential topline from a single block: ₹250-300 Cr.
- · CDMO/CMO revenue guidance of ~USD 100 million (₹~835 Cr) in the long-term.
- · Xanthine derivatives expansion adding 3,000 MTPA incremental capacity (from 6,000 to 9,000 MTPA); incremental capacity available for production by end of current quarter.
- · Steroid block debottlenecking at Tarapur Unit-4 increased capacity by about one-third.
- · Investment in R&D of tides (peptides and oligonucleotides) stated as a new technology push.
- · Board declared final dividend of ₹2 per share, total FY2026 dividend ₹3.50 per share.
- · Capex for FY2026 was ₹400 Cr; similar level planned for FY2027.
- · API/intermediate segment FY2026 revenue declined to ~₹600 Cr from ~₹700 Cr in FY2025; management expects to surpass FY2025 level in FY2027.
- · Inflationary pressures from Middle East geopolitical tensions impacting logistics and energy costs; Xanthine segment partially able to pass on price increases; intermediate segment faces difficulty in cost pass-through.
- · CDMO/CMO segment targeting ₹1,000 Cr revenue by FY2028 or FY2029 (from earlier guidance).
01-06-2026
Sigma Advanced Systems Limited (formerly Megasoft Limited) has informed the stock exchanges that a Board meeting is scheduled for June 4, 2026, to consider issuing equity shares on a preferential basis and to convene an Extra-Ordinary General Meeting for shareholder approval. The trading window for designated persons has been closed immediately until 48 hours after the board meeting.
- · The company is considering issuing equity shares on a preferential basis under SEBI (Issue of Capital and Disclosure Requirements) Regulations, 2018.
- · An Extra-Ordinary General Meeting will be convened to seek shareholder approval for the preferential issue.
- · The trading window for designated persons is closed with immediate effect until 48 hours after the board meeting conclusion.
01-06-2026
Astra Microwave Products reported a strong FY26 with consolidated turnover of ₹1157 Cr, in line with guidance, and a robust order book of ₹2141 Cr as of March 31, 2026. Operating cash flow improved significantly to ₹370 Cr from a negative ₹99 Cr in the prior year. However, the company's joint venture Astra Rafael Comsys saw profitability impacted by forex-related provisions, though it is expected to deliver over ₹600 Cr in revenue in FY27.
- · Board recommended dividend of ₹2.40 per equity share (120% of face value) for FY25-26, subject to shareholder approval.
- · Radar business contributed nearly 60% of FY26 revenue; space and meteorology segment contributed around 16%.
- · Astra Rafael Comsys booked orders worth ₹546 Cr in FY26 and achieved sales of ₹360 Cr.
- · FY27 planned sales of ₹1,300-1,400 Cr, with 40% from R&D and 60% from production.
- · The company has in-principle approved demerger of space, meteorology, and hydrology business to sharpen strategic focus.
- · Astra has evolved from a tier-2 subsystem supplier to a development-cum-production partner for strategic national programs.
01-06-2026
SAR Televenture Limited has launched an open offer to acquire up to 79,11,800 equity shares (26% of total equity) of Grand Foundry Limited at ₹2.50 per share, payable in cash. The offer opens on June 9, 2026 and closes on June 22, 2026, with no minimum acceptance condition. However, the offer price of ₹2.50 per share is significantly below the negotiated price of ₹1.50 per share mentioned in the SPA, and the offer carries several completion risks including potential delays from litigation or SEBI instructions, with tendered shares being locked in during the process.
- · The offer is made under Regulations 3(1) and 4 of SEBI (SAST) Regulations, 2011.
- · The offer is not conditional on any minimum level of acceptance.
- · There is no competing offer.
- · The Identified Date for mailing the Letter of Offer was revised from April 16, 2026 to May 25, 2026.
- · The offer price may be revised upward up to 3 working days before the opening of the tendering period (i.e., by June 4, 2026).
- · In case of oversubscription, acceptance will be on a proportionate basis.
- · Public shareholders who tender shares cannot withdraw their acceptance during the tendering period.
- · Tendered shares will be held in trust and cannot be traded during the offer process, exposing shareholders to market price fluctuations.
- · The Acquirer and Manager accept no responsibility for statements made outside the official offer documents.
- · No statutory approvals are required for the offer.
01-06-2026
Ipca Laboratories Limited held a conference call on June 1, 2026 to discuss its Q4FY26 earnings and business update. The audio link of the call has been made available on the company's website. No specific financial figures or performance details are provided in this filing.
- · Conference call held on June 1, 2026 from 15:30 hrs IST.
- · Audio link available at https://www.ipca.com/shareholders-information-conference-calls-concall-transcripts/
- · Filing made pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
01-06-2026
DC Infotech & Communication Limited has informed the stock exchanges that it will hold an investor call (Q4 FY26 Post Result Conference Call) on June 4, 2026, at 2:00 PM IST. The filing is a procedural intimation under Regulation 30 of SEBI LODR and does not contain any financial results or performance data.
- · The investor call is scheduled for Thursday, June 04, 2026 at 2:00 PM IST.
- · The call is titled 'Q4 FY26 Post Result Conference Call'.
- · The company's symbol on NSE is DCI and ISIN is INE0A1101019.
- · The company's registered office is in Andheri (E), Mumbai, Maharashtra.
01-06-2026
Zydus Lifesciences Limited announced a buyback of up to 87,30,158 equity shares (0.87% of paid-up capital) at ₹1,260 per share, for an aggregate amount not exceeding ₹1100,00,00,000 (₹1,100 Crore). The buyback opens on June 4, 2026 and closes on June 10, 2026, via the tender offer route on a proportionate basis. Small shareholders are entitled to a buyback ratio of 5 shares for every 49 held, while general shareholders are entitled to 7 shares for every 937 held.
- · Record date for determining eligible shareholders: May 29, 2026.
- · Buyback is within the statutory limit of 10% of paid-up capital and free reserves under the board approval route.
- · The buyback is conducted under Sections 68, 69, 70, 179 of the Companies Act and SEBI Buyback Regulations.
- · Escrow account and firm financial arrangements are detailed in the Letter of Offer.
- · The Letter of Offer is available on the websites of the Company, Manager, Registrar, SEBI, NSE, and BSE.
- · Eligible shareholders can check their entitlement online via the Registrar's website.
- · The buyback is not an offer in any jurisdiction outside India.
01-06-2026
Maxgrow India Ltd held its Annual General Meeting on June 1, 2026, to adopt audited financial statements for five financial years (FY2021–FY2025) and appoint key managerial personnel and auditors. The meeting marks a significant step in regularizing statutory compliances after the company's Corporate Insolvency Resolution Process (CIRP), which was initiated in June 2021 and concluded with the approval of a resolution plan by PP Metallix Limited in December 2023. While the company is now focusing on strengthening governance and compliance, the filing does not disclose any financial performance metrics, making it impossible to assess operational or financial health.
- · The AGM adopted audited standalone financial statements for FY2021, FY2022, FY2023, FY2024, and FY2025.
- · M/s. R. B. Jain & Associates was appointed as Statutory Auditor.
- · Secretarial Auditors were appointed via ordinary resolution.
- · Three Independent Directors (Ms. Pooja Pravin Keer, Mr. Laxman Medudula, Mr. Amarjit Kumar Shrivastav) and one Non-Executive Non-Independent Director (Mr. Guda Rakesh) were appointed.
- · Mr. Shivkumar Ramsagar Pasi was appointed as Managing Director via special resolution, with remuneration to be fixed.
- · The company provided remote e-voting through MUFG Intime India Private Limited and polling papers at the AGM.
- · The CIRP was initiated by NCLT Mumbai on June 4, 2021, and the resolution plan by PP Metallix Limited was sanctioned on December 6, 2023.
01-06-2026
Supra Pacific Financial Services Limited has informed BSE that a Board Meeting will be held on June 04, 2026, to consider, among other items, the issuance of secured, unrated, unlisted Non-convertible Debentures (NCDs) above ₹1 crore. The meeting will also review business operations and prospects. No financial results or period-over-period comparisons are included in this filing.
- · Board Meeting scheduled for Thursday, June 04, 2026 at 10:30 a.m.
- · Agenda includes confirmation of previous Board Meeting minutes, approval of NCD issuance above ₹1 crore, and review of business operations and prospects.
- · Toll-free number: 1800-120-199666
01-06-2026
Goldiam International Limited has issued a postal ballot notice seeking shareholder approval for the issuance of bonus equity shares in a 1:3 ratio (one new share for every three held), capitalizing up to ₹7,52,78,562 from reserves. The remote e-voting period runs from June 2, 2026 to July 1, 2026, with results expected within two working days thereafter. This is a routine corporate action requiring ordinary resolution approval and does not reflect any financial performance changes.
- · E-voting starts on June 2, 2026 at 9:00 AM IST and ends on July 1, 2026 at 5:00 PM IST.
- · Members holding shares in physical mode must update email addresses with the Company or RTA to receive voting credentials.
- · The bonus shares will rank pari passu with existing equity shares and will be allotted only in dematerialized form.
- · Fractional shares will be sold by a trustee and net proceeds distributed proportionally to entitled members.
- · The nomination and remuneration committee is authorized to adjust the Employee Stock Option Scheme 2024 in consequence of the bonus issue.
01-06-2026
Alka India Ltd (now AUDROC Limited) held a Board Meeting on June 1, 2026, approving the issuance of up to 20,00,00,000 fully convertible equity warrants on a preferential basis at ₹4 per warrant, aggregating ₹80,00,00,000 (Eighty Crores). The warrants are convertible into equity shares within 18 months, with 25% payable upfront. The Board also accepted the resignation of Secretarial Auditor M/s J.D. Khatnani & Associates and appointed M/s Avni & Associates as the new Secretarial Auditor, along with appointing M/s J M Patel & Bros as Tax Auditor for FY 2026-27. An Extraordinary General Meeting is scheduled for June 27, 2026, to seek shareholder approval for the warrant issuance.
- · The company name has changed to AUDROC Limited (formerly Alka India Limited).
- · The Board Meeting started at 3:30 PM and concluded at 3:45 PM on June 1, 2026.
- · M/s J.D. Khatnani & Associates resigned as Secretarial Auditor due to professional commitments and pre-occupations, effective June 1, 2026, subject to submission of the Annual Secretarial Compliance Report for FY 2025-26.
- · M/s Avni & Associates has been appointed as Secretarial Auditor up to the conclusion of the AGM for FY 2026-27.
- · M/s J M Patel & Bros has been appointed as Tax Auditor for FY 2026-27.
- · The EGM will be held on June 27, 2026, through video conferencing.
- · Post-allotment shareholding (assuming full conversion) shows the six allottees will hold between 12.71% and 18.16% each, with Patel Vandanaben Hiteshkumar's stake increasing from 50.00% pre-preferential to 13.68% post-allotment.
01-06-2026
Glenmark Pharmaceuticals has informed the stock exchanges that the audio recording of its Q4 FY 2025-26 earnings call, held on June 1, 2026, has been uploaded to the company's website. This filing is a procedural disclosure under SEBI regulations and does not contain any financial results or performance data.
- · The audio recording is available at: https://glenmark.b-cdn.net/gpl_pdfs/Financials/Quarterly/Earnings%20Call%20Recording%20Q4%20FY26.mp3
- · The filing was made under Regulation 30 and 46 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
- · The company's CIN is L24299MH1977PLC019982.
Get daily alerts with 11 investment signals, 10 risk alerts, 10 opportunities and full AI analysis of all 50 filings
₹500/mo after a 14-day free trial — no credit card required. See pricing or explore intelligence streams.
More from: India Stock Market Daily Regulatory Digest
🇮🇳 More from India
View all →June 02, 2026
India Quarterly Results BSE NSE Announcements — June 02, 2026
India Quarterly Results BSE NSE Announcements
June 02, 2026
India Upcoming Corporate Actions BSE NSE — June 02, 2026
India Upcoming Corporate Actions BSE NSE
June 02, 2026
India Pre-Market Regulatory Roundup — June 02, 2026
India Pre-Market Regulatory Roundup
June 02, 2026
BSE Realty Real Estate Sector Regulatory Filings — June 02, 2026
BSE Realty Real Estate Sector Regulatory Filings